Men with large prostates experience more relief from BPH with treatment by Aquablation therapy (using the AquaBeam System) than with transurethral resection of the prostate, researchers say.
AUA Annual Meeting
Many urologists don't follow guidelines calling on them to image their patients after ureteroscopic stone disease treatment, researchers say.
Henry Rosevear, MD, explains how he left the AUA annual meeting in San Francisco a smarter urologist.
Statin use by patients with advanced prostate cancer who are undergoing treatment with androgen deprivation therapy may increase overall survival and prostate cancer-specific survival.
A private urology practice can successfully transform itself from a fee-for-service payment model for cancer care to an episode-based system, although it remains to be determined whether operating under this model also translates into cost savings.
“Patients should be informed of the less-than-ideal stone-free rates and secondary morbidity when residual fragments are present after this treatment modality,” says researcher Igor Sorokin, MD.
The decline occurred despite a consistent number of monthly clinical encounters with a primary diagnosis of hypogonadism.
The analysis “gives urologists the first accurate idea of how many physician assistants and nurse practitioners are working in urology,” says researcher Raymond Fang.
New study findings provide evidence to guide management decisions for patients with prostate cancer who have lymph node metastases following radical prostatectomy.
The association between testosterone replacement therapy (TRT) and thrombotic risk in elderly men remains controversial. While the FDA has mandated that all approved testosterone products include warnings about a possible increase in cardiovascular, stroke, and venous blood clot risk, at least one study presented at the AUA annual meeting in New Orleans found no link between TRT and cardiovascular events.